- Open Access
Runx transcription factors in neuronal development
© Inoue et al.; licensee BioMed Central Ltd. 2008
- Received: 09 June 2008
- Accepted: 26 August 2008
- Published: 26 August 2008
Runt-related (Runx) transcription factors control diverse aspects of embryonic development and are responsible for the pathogenesis of many human diseases. In recent years, the functions of this transcription factor family in the nervous system have just begun to be understood. In dorsal root ganglion neurons, Runx1 and Runx3 play pivotal roles in the development of nociceptive and proprioceptive sensory neurons, respectively. Runx appears to control the transcriptional regulation of neurotrophin receptors, numerous ion channels and neuropeptides. As a consequence, Runx contributes to diverse aspects of the sensory system in higher vertebrates. In this review, we summarize recent progress in determining the role of Runx in neuronal development.
- Dorsal Root Ganglion
- Dorsal Root Ganglion Neuron
- Nociceptive Neuron
- Runx1 Expression
- Runx Protein
Runt related (Runx) genes are evolutionarily conserved developmental regulators in metazoa, where they play diverse roles in several different biological systems, including cell differentiation. One of the Drosophila pair-rule genes, Runt, controls segmentation, sex-determination and neuronal development . The mammalian Runx gene was first identified as AML1, which is frequently involved in the chromosomal translocations associated with acute myeloid leukaemia (AML) . Both Runt and AML1 encode a DNA binding subunit of the heterodimeric transcription factor PEBP2/CBF. Polyomavirus enhancer binding complex (PEBP2/PEA2) was identified during the characterization of the cellular mechanisms involved in differentiation using embryonal carcinoma cells . CBF was first identified as a protein that binds to the core sequence of the murine retrovirus enhancer, which influences the tissue specificity of viral replication .
There are three mammalian RUNX genes, RUNX1 (AML1), RUNX2 (CBFA1) and RUNX3 . RUNX1 is essential for definitive hematopoiesis and frequently involved in human leukaemia . Runx2 is a master regulator of bone development . Moreover, haploinsufficiency of RUNX2 is one of the causes of the hereditary bone disease Cleidcranial displasia . RUNX3, the third member of the RUNX gene family, was the least characterized until gene targeting studies opened up new avenues of investigation into Runx function. First of all, RUNX3 is involved in many types of human cancer as a tumour suppressor [9, 10]. Hypermethylation of the RUNX3 promoter and deletion of the RUNX3 gene are frequently observed in several cancers, and RUNX3 protein is now best considered as an apoptosis inducer [11, 12]. Second, RUNX3 controls the generation of the T-cell sub-lineage [13–15]. In particular, transcriptional regulation of CD4 silencer and Th-POK have been described in detail [13, 15]. Finally, Runx3 controls the development of proprioceptive dorsal root ganglion (DRG) neurons [16, 17]. The last discovery was particularly relevant to developmental neurobiology and, since then, several groups have characterized not only Runx3, but also Runx1 as a crucial regulator of DRG neurogenesis [18, 19].
Expression of Runx1 and Runx3 in the nervous system
Earlier in situ hybridization studies indicated strong expression of Runx1 mRNA in spinal motor neurons, DRG, cranial ganglia and specialized sensory epithelial structures such as olfactory and gustatory mucosa, and follicles of the vibrissae . Subsequently, the generation of specific antibodies against Runx1 and Runx3 and the utilization of Runx1 β-gal or Runx3 β-gal mice revealed the expression of Runx1 and Runx3 in the nervous system in more detail [16, 21, 22]. Runx1 is synthesized in both the central and peripheral nervous systems of mouse embryos. In the central nervous system, Runx1 is synthesized in selective populations of somatic motor neurons in the spinal cord and in cholinergic branchial and visceral motor neurons in the hindbrain, such as dorsal vagal nucleus and nucleus ambiguus [21, 22]. In the peripheral nervous system, Runx1 is localized to DRG and selective cranial ganglia, including trigeminal (V) and vestibulocochlear (VIII) ganglia and the glossopharyngeal-vagal (IX-X) ganglia complex [21, 22]. In contrast to Runx1, Runx3 is confined to the peripheral nervous system, specifically to DRG and cranial ganglia [16, 21]. Although Runx1 and Runx3 are almost exclusively found in postmitotic neurons in the central nervous system and peripheral ganglia [16, 21, 22], a rare exception is the expression of Runx1 in proliferating progenitors of the olfactory epithelium . These observations suggest Runx1 and Runx3 have extensive functions in the mammalian nervous system.
Roles of Runx3 in the development of DRG neurons
First, the role of Runx3 in the neurotrophin receptor phenotype was shown by Arber and her colleagues , who thoroughly compared neurotrophin receptor synthesis in mouse strains in which Runx3 had been disrupted or expressed ectopically. In DRG neurogenesis, dynamic changes are observed during the synthesis of neurotrophin receptors (TrkB, TrkC) . At early developmental stages, most DRG neurons synthesize TrkC protein first before the onset of TrkB synthesis. Thus, some TrkC+ DRG neurons co-synthesize TrkB (Figure 1a). Subsequently, the ratio of TrkB/TrkC-hybrid neurons declines to produce DRG neurons that synthesize either TrkC or TrkB (Figure 1a). During this segregation, Runx3 is observed in most TrkC+ neurons but not in TrkB+ neurons . One of the functions of Runx3 is to repress TrkB when DRG neurons acquire TrkC+ identity (Figure 1a) .
Second, the axonal outgrowth and/or axonal guidance of propiroceptive DRG neurons are also regulated by Runx3. Two different interpretations were proposed for the phenotype of the Runx3-/- DRG. One group proposed that Runx3 controls the appropriate axon targeting of trkC-expressing proprioceptive DRG neurons to motor neurons . However, another group observed massive cell death of TrkC+ neurons in Runx3-/- DRG in apparent contradiction to the previous proposition . A recent study with Runx3 and Bax-double knockout mouse revealed clearly that the axonal projection of propioceptive DRG neurons to motor neurons is still lost in the Runx3 mutant even in the absence of apoptosis . The study further clarified that the initial model 'Runx3 → TrkC and Runx1 → TrkA' might not apply to later developmental stages . They observed that Runx3 co-localizes not only with TrkC, but also TrkA and TrkB at postnatal day 0 (P0) . Of note, Runx1+ and Runx3+ neurons were clearly segregated at embryonic day 16.5 (E16.5) but almost all Runx3+ neurons co-synthesize Runx1 at E18.5 and P0 . It is possible that Runx3 has some functions not only in proprioceptive neurons, but also in nociceptive neurons . Overall, the evidence obtained from Runx3 and Bax compound mutants support a role for Runx3 in the control of axonal projection, although the molecular mechanisms remain unknown . Prior studies showed that DRG explants from Runx3-knockout mouse embryos extended short neurites in the presence of NT3, a ligand for TrkC, but not in the presence of NGF, a ligand for TrkA . This suggests that Runx3 may regulate the axonal outgrowth of specific DRG neurons independently of the target tissue. On the other hand, Chen et al.  revealed, using a tour de force method, that Runx3 activity determines the dorso-ventral position of axonal termination of DRG neurons in the spinal cord. DRG neurons with high Runx3 activity extended their axons far into the ventral spinal cord like proprioceptive neurons, whereas those neurons with low Runx3 activity extended their axons into the dorsal spinal cord. Ectopic expression of Runx3 is sufficient to drive axons from the dorsal to the ventral spinal cord, indicating that Runx3 per se has instructive roles in central axon targeting in DRG neurons.
Thus, Runx3 controls the neurotrophin receptor phenotype as well as the axonal projection of proprioceptive DRG neurons. The two functions may not be mutually exclusive but closely related to each other. For example, NGF/TrkA signalling and NT3/TrkC signalling are required for proper axonal projection [31, 32].
Roles of Runx1 in the development of DRG neurons
In contrast to Runx3, the study of Runx1 function in DRG development was delayed owing to the early embryonic lethality of the targeting mouse [22, 23, 33]. Thus, Runx1 knockout mice die due to a lack of definitive hematopoiesis by E12.5, which is before the onset of major events in the development of TrkA+ DRG neurons. However, recent studies have investigated the roles of Runx1 in DRG neurons using different experimental models.
First of all, Runx1 controls the lineage diversification of nociceptive neurons [25, 33, 34]. During late embryonic and early postnatal periods, trkA-expressing neurons differentiate into two subpopulations of nociceptive neurons; trkA-retaining peptidergic neurons, and non-peptidergic neurons that repress trkA and instead activate Ret, a receptor for glial-derived neurotrophic factor (GDNF; Figure 1b). During the late embryonic stages, most trkA-expressing DRG neurons coexpress Runx1 (Figure 1b). Postnatally, Runx1 disappears in trkA-retaining peptidergic neurons but continues to exist in Ret-inducing non-peptidergic neurons (Figure 1b). Using the Runx1-conditional knockout mouse, it was shown that Runx1 is dispensable for the de novo induction of TrkA . This was confirmed by Shiga and his colleagues , who used a different gene-targeting method that relied on the rescuing of Runx1 expression in hematopoietic cells. However, Marmigere et al.  showed that virally expressed Runx1 induced de novo synthesis of TrkA in the DRG and spinal cord of chick embryos. One possible explanation is that the minimal enhancer of trkA, which Runx1 regulates , may not be required for the de novo induction of trkA expression . On the other hand, Runx1 is essential for the late repression of trkA and induction of Ret when TrkA+ and Ret+ neurons segregate (Figure 1b) . In addition to trkA, Runx1 also represses the neuropeptide, calcitonin-gene-related peptide (CGRP; Figure 1b) [25, 33, 34]. More surprisingly, nearly all the known marker genes for nociception are under the control of Runx1. In the conditional Runx1 mutant DRG, expression of a number of nociceptor-specific G protein coupled receptors, ATP channels, and TRPV channels is attenuated (Figure 1b) .
Similar to Runx3, Runx1 also regulates the axonal outgrowth and guidance of nociceptive neurons. Marmigere et al.  revealed that the transfection of Runx1 into boundary cap-derived neural crest stem cells increased neurite length and branching. In Runx1-knockout mice, the axonal projection to laminae IIi of the dorsal spinal cord was perturbed [33, 34]. In the wild type, peptidergic nociceptive axons project to layer I/IIo in the superficial dorsal horn, whereas non-peptidergic nociceptive axons project to deeper layer IIi. In Runx1-knockout mouse, non-peptidergic axonal projection displays dorsal shift to layer I/IIo .
Thus, Runx1 controls a battery of genes that are associated with the generation of non-peptidergic nociceptive neurons. The findings that both Runx3 and Runx1 play critical roles in distinct sensory neurons suggest that Runx factors are involved in the evolution of sophisticated sensory systems in higher vertebrates.
The upstream signals and transcriptional regulation of RUNX genes have been studied in non-neuronal tissues . However, only limited studies have addressed this issue in the nervous system. Both Runx3 and Runx1 genes contain Brn-3a binding sites in their 5'-upstream regions, suggesting that Runx3 and Runx1 are candidate downstream targets of Brn-3a, a well characterized transcription factor in sensory neurons [38, 39]. Microarray studies have shown decreased levels of Runx1 and Runx3 transcripts in the sensory neurons of Brn-3a-knokout mice [40, 41]. Kramer et al.  investigated the putative upstream signal of Runx1/Runx3 in DRG neurons. Plausible candidates are TrkC/TrkA signalling and the basic helix-loop-helix transcription factors Ngn2/Ngn1; however, a genetic study has excluded these possibilities . Ginty and colleagues  investigated the roles of NGF and the Ret receptor in DRG neurons. In Ngf-Bax compound knockout DRG, TrkA neurons are hypotrophic although de novo Runx1 expression is unaffected . However, Runx1 expression is not maintained to the neonate stage and the expression of all putative Runx1 target genes is altered . Thus, NGF signalling is essential for sustained expression of Runx1. In Ret conditional knockout DRG, Runx1 expression is normal but a part of Runx1 target genes are affected, suggesting the GFR/Ret dependent transcriptional regulation by Runx1 in DRG neurons . Although this study placed Runx in a pivotal position in developmental signalling cascades, the upstream signalling event(s) still remains elusive.
On the other hand, how does Runx1/Runx3 regulate downstream transcriptional cascades? In DRG neurons, TrkC is a critical signalling receptor involved not only in the control of cell survival, but also in axon path-finding and fate determination of proprioceptive DRG neurons [32, 43, 44]. Therefore, it is natural to infer that trkC is a transcriptional target of Runx3 . However, unbiased computational analysis suggested that a cis-regulatory element exists in the gene locus of TrkB, rather than in the gene locus of TrkC . This was unexpected because trkB is expressed in neurons of an alternative sensory fate, TrkB+TrkC- neurons . The strategy "to repress alternative traits" appears to be a common feature in neuronal lineage commitment . At the molecular level, trkB possesses a conserved cluster of Runx binding sites that function as a silencer of the trkB promoter in cultured DRG neurons . In Runx3 knockout DRG, derepression of trkB seems to be a crucial event, influencing lineage commitment [25, 45], and, eventually, resulting in drastic behavioural consequences [16, 17].
Runx protein works both as an activator and repressor, depending on the molecular context . The finding that Runx3 represses trkB raises a question as to the identities of its partner molecules in the transcriptional repressor complex. The function of Runx1 as a transcriptional repressor has been widely studied [48, 49]. A plausible candidate in the context of DRG is the Groucho corepressor. In motoneuron fate specification, Groucho-mediated repression is a common mechanism for homeodomain proteins containing the EH1 domain . Runx proteins have the evolutionarily conserved VWRPY carboxy-terminal motif, which is considered to be critical for Groucho binding/function [50, 51]. Yarmus et al.  generated mice in which Runx3 lacks these amino acids. Surprisingly, VWRPY knockout mice displayed the normal development in DRG neurons, though they showed the phenocopy to Runx3 knockout mice in dendritic cells . The results suggest that Runx3 represses trkB through a Groucho independent mechanism. Recently, Ma and his colleagues  investigated the significance of the VWRPY motif of Runx1 in DRG neurons. Runx1 cDNA, which lacks the VWRPY coding sequence, was knocked into the native Runx1 locus in delta446 mice . In the delta446 mice, derepression of Mrg class G-protein-coupled receptor genes was observed, suggesting that Mrg genes are repressed by a Groucho-dependent mechanism (Figure 1c) . Interestingly, two putative target genes that are repressed by Runx1, trkA and CGRP, were unaffected in the delta446 mice . These results suggest that Runx1 represses target genes through either a Groucho-dependent or an independent mechanism in DRG neurons.
Chen et al.  indicated that Runx1 controls nearly all known marker genes critical for nociceptive functions. Such global control by Runx over the transcription landscape is also observed in other physiological functions, such as hematopoietic stem cell formation (Runx1) and osteoblast maturation (Runx2). How this unique transcription factor has such a huge influence on many different transcriptional cascades remains a challenging question.
Other neurological phenotypes of Runx1/Runx3 knockout mice
Stifani and his colleagues [22, 23] have worked on the neurological phenotypes of the Runx1 knockout mouse other than those arising from defects in DRG neurons. They analysed the cranial sensory neurons as well as cholinergic branchial and visceral motor neurons of hindbrain at an early embryonic stage . The expression of Runx1 was restricted to post-mitotic neurons, and disruption of Runx1 resulted in massive neuronal apoptosis . In contrast to this finding, Runx1 is expressed in the proliferating neuronal progenitors/precursors of olfactory receptor neurons (ORNs) . Runx1 drives the cell cycle in ORN progenitors through transcription repression of the cyclin dependent kinase inhibitor p21 . Unlike DRG, they did not observe any changes in the lineage markers in the neurons examined (cranial, hindbrain and olfactory), indicating that Runx1 has distinct functions in different types of neurons [22, 23].
The study of the neurological function of Runx3 other than in DRG is very limited. Levanon et al.  reported that TrkC+ neurons in the trigeminal ganglion survive in contrast to DRG neurons in Runx3-/- mouse. Most Runx3 knockout mice of the C57/B6 strain die within one day after birth [9, 16]. The main cause of death may be starvation, as little milk is found in the stomachs of these mice . As this is probably related to the pups being unable to swallow milk, it is interesting to note that Runx3 is strongly expressed in cranial ganglia, including the glossopharyngeal ganglion [16, 17]. It is possible that Runx3 is essential for the functional glossopharyngeal system (swallowing), suggesting the critical roles in developmental cranial neurons.
Although the roles of Runx in neural development have just begun to be investigated, studies in gene knockout mice indicate that the roles of Runx in the nervous system are as important as its roles in other, non-neuronal tissues. However, a number of open questions should be addressed in the future. First, upstream signalling cascades remain elusive. The mRNA expression and protein synthesis for Runx1/Runx3 are tightly regulated and DRG is one of the tissues in which Runx1/Runx3 display their highest protein levels among the entire body; how do DRG neurons achieve such a high protein level for Runx1/Runx3? Second, the molecular bases of tissue specificity are largely unknown. Runx1 and Runx3 are highly homologous but they control the development of distinct subpopulations of sensory neurons. In particular, Runx1+ neurons and Runx3+ neurons project axons into totally different target tissues; how is this specificity achieved? Third, transcriptional regulation is not the only determinant of DRG neurogenesis. Ectopic synthesis of TrkC receptor per se influences the lineage commitment of DRG neurons , while Runx3 plays a crucial role in TrkB/TrkC status [25, 45]. It is likely that Runx and neurotrophin status are closely related to each other. How this cross-regulation is carried out is a challenging question. Finally, since all three Runx proteins have common features, some of the knowledge about Runx function in oncology, haematology, immunology and bone biology is likely to be applicable to neuroscience as well, particularly at the molecular level .
Work in the laboratory of YI is funded by A*STAR (Agency for Science, Technology and Research). TS is supported by Grant-in-Aid for Scientific Research from the 21st Century COE Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.
- Duffy JB, Gergen JP: Sex, segments, and the central nervous system: common genetic mechanisms of cell fate determination. Adv Genet. 1994, 31: 1-28.View ArticlePubMedGoogle Scholar
- Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci U S A. 1991, 88: 10431-10434.PubMed CentralView ArticlePubMedGoogle Scholar
- Ito Y: RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res. 2008, 99: 33-76.View ArticlePubMedGoogle Scholar
- Speck NA, Terryl S: A new transcription factor family associated with human leukemias. Crit Rev Eukaryot Gene Expr. 1995, 5: 337-364.View ArticlePubMedGoogle Scholar
- Ito Y: Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells. 1999, 4: 685-696.View ArticlePubMedGoogle Scholar
- Speck NA, Gilliland DG: Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002, 2: 502-513.View ArticlePubMedGoogle Scholar
- Komori T: Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 2006, 99: 1233-1239.View ArticlePubMedGoogle Scholar
- Mundlos S: Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet. 1999, 36: 177-182.PubMed CentralPubMedGoogle Scholar
- Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002, 109: 113-124.View ArticlePubMedGoogle Scholar
- Ito Y: Oncogenic potential of the RUNX gene family: 'overview'. Oncogene. 2004, 23: 4198-4208.View ArticlePubMedGoogle Scholar
- Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y: RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 2005, 65: 7743-7750.View ArticlePubMedGoogle Scholar
- Yano T, Ito K, Fukamachi H, Chi XZ, Wee HJ, Inoue K, Ida H, Bouillet P, Strasser A, Bae SC, Ito Y: The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol. 2006, 26: 4474-4488.PubMed CentralView ArticlePubMedGoogle Scholar
- Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR: Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002, 111: 621-633.View ArticlePubMedGoogle Scholar
- Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM: Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol. 2007, 8: 145-153.View ArticlePubMedGoogle Scholar
- Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I: Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science. 2008, 319: 822-825.View ArticlePubMedGoogle Scholar
- Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y: Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci. 2002, 5: 946-954.View ArticlePubMedGoogle Scholar
- Levanon D, Bettoun D, Harris-Cerruti C, Woolf E, Negreanu V, Eilam R, Bernstein Y, Goldenberg D, Xiao C, Fliegauf M, Kremer E, Otto F, Brenner O, Lev-Tov A, Groner Y: The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 2002, 21: 3454-3463.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhong J, Pevny L, Snider WD: "Runx"ing towards sensory differentiation. Neuron. 2006, 49: 325-327.View ArticlePubMedGoogle Scholar
- Marmigere F, Ernfors P: Specification and connectivity of neuronal subtypes in the sensory lineage. Nat Rev Neurosci. 2007, 8: 114-127.View ArticlePubMedGoogle Scholar
- Simeone A, Daga A, Calabi F: Expression of runt in the mouse embryo. Dev Dyn. 1995, 203: 61-70.View ArticlePubMedGoogle Scholar
- Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E, Eilam R, Lotem J, Gat U, Otto F, Speck N, Groner Y: Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev. 2001, 109: 413-417.View ArticlePubMedGoogle Scholar
- Theriault FM, Roy P, Stifani S: AML1/Runx1 is important for the development of hindbrain cholinergic branchiovisceral motor neurons and selected cranial sensory neurons. Proc Natl Acad Sci U S A. 2004, 101: 10343-10348.PubMed CentralView ArticlePubMedGoogle Scholar
- Theriault FM, Nuthall HN, Dong Z, Lo R, Barnabe-Heider F, Miller FD, Stifani S: Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system. J Neurosci. 2005, 25: 2050-2061.View ArticlePubMedGoogle Scholar
- Chen AI, de Nooij JC, Jessell TM: Graded activity of transcription factor Runx3 specifies the laminar termination pattern of sensory axons in the developing spinal cord. Neuron. 2006, 49: 395-408.View ArticlePubMedGoogle Scholar
- Kramer I, Sigrist M, de Nooij JC, Taniuchi I, Jessell TM, Arber S: A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification. Neuron. 2006, 49: 379-393.View ArticlePubMedGoogle Scholar
- Ernfors P, Lee KF, Kucera J, Jaenisch R: Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell. 1994, 77: 503-512.View ArticlePubMedGoogle Scholar
- Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF: Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature. 1994, 369: 658-661.View ArticlePubMedGoogle Scholar
- Klein R, Silos-Santiago I, Smeyne RJ, Lira SA, Brambilla R, Bryant S, Zhang L, Snider WD, Barbacid M: Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature. 1994, 368: 249-251.View ArticlePubMedGoogle Scholar
- Tessarollo L, Vogel KS, Palko ME, Reid SW, Parada LF: Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons. Proc Natl Acad Sci U S A. 1994, 91: 11844-11848.PubMed CentralView ArticlePubMedGoogle Scholar
- Nakamura S, Senzaki K, Yoshikawa M, Nishimura M, Inoue KI, Ito Y, Ozaki S, Shiga T: Dynamic regulation of the expression of neurotrophin receptors by Runx3. Development. 2008, 135 (9): 1703-17011.View ArticlePubMedGoogle Scholar
- Patel TD, Jackman A, Rice FL, Kucera J, Snider WD: Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron. 2000, 25: 345-357.View ArticlePubMedGoogle Scholar
- Patel TD, Kramer I, Kucera J, Niederkofler V, Jessell TM, Arber S, Snider WD: Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferents. Neuron. 2003, 38: 403-416.View ArticlePubMedGoogle Scholar
- Yoshikawa M, Senzaki K, Yokomizo T, Takahashi S, Ozaki S, Shiga T: Runx1 selectively regulates cell fate specification and axonal projections of dorsal root ganglion neurons. Dev Biol. 2007, 303: 663-674.View ArticlePubMedGoogle Scholar
- Chen CL, Broom DC, Liu Y, de Nooij JC, Li Z, Cen C, Samad OA, Jessell TM, Woolf CJ, Ma Q: Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain. Neuron. 2006, 49: 365-377.View ArticlePubMedGoogle Scholar
- Marmigere F, Montelius A, Wegner M, Groner Y, Reichardt LF, Ernfors P: The Runx1/AML1 transcription factor selectively regulates development and survival of TrkA nociceptive sensory neurons. Nat Neurosci. 2006, 9: 180-187.PubMed CentralView ArticlePubMedGoogle Scholar
- Ma L, Merenmies J, Parada LF: Molecular characterization of the TrkA/NGF receptor minimal enhancer reveals regulation by multiple cis elements to drive embryonic neuron expression. Development. 2000, 127: 3777-3788.PubMedGoogle Scholar
- Levanon D, Groner Y: Structure and regulated expression of mammalian RUNX genes. Oncogene. 2004, 23: 4211-4219.View ArticlePubMedGoogle Scholar
- Bangsow C, Rubins N, Glusman G, Bernstein Y, Negreanu V, Goldenberg D, Lotem J, Ben-Asher E, Lancet D, Levanon D, Groner Y: The RUNX3 gene--sequence, structure and regulated expression. Gene. 2001, 279: 221-232.View ArticlePubMedGoogle Scholar
- Levanon D, Glusman G, Bangsow T, Ben-Asher E, Male DA, Avidan N, Bangsow C, Hattori M, Taylor TD, Taudien S, Blechschmidt K, Shimizu N, Rosenthal A, Sakaki Y, Lancet D, Groner Y: Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene. 2001, 262: 23-33.View ArticlePubMedGoogle Scholar
- Eng SR, Lanier J, Fedtsova N, Turner EE: Coordinated regulation of gene expression by Brn3a in developing sensory ganglia. Development. 2004, 131: 3859-3870.View ArticlePubMedGoogle Scholar
- Eng SR, Dykes IM, Lanier J, Fedtsova N, Turner EE: POU-domain factor Brn3a regulates both distinct and common programs of gene expression in the spinal and trigeminal sensory ganglia. Neural Develop. 2007, 2: 3-PubMed CentralView ArticleGoogle Scholar
- Luo W, Wickramasinghe SR, Savitt JM, Griffin JW, Dawson TM, Ginty DD: A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons. Neuron. 2007, 54: 739-754.View ArticlePubMedGoogle Scholar
- Snider WD: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell. 1994, 77: 627-638.View ArticlePubMedGoogle Scholar
- Moqrich A, Earley TJ, Watson J, Andahazy M, Backus C, Martin-Zanca D, Wright DE, Reichardt LF, Patapoutian A: Expressing TrkC from the TrkA locus causes a subset of dorsal root ganglia neurons to switch fate. Nat Neurosci. 2004, 7: 812-818.PubMed CentralView ArticlePubMedGoogle Scholar
- Inoue K, Ito K, Osato M, Lee B, Bae SC, Ito Y: The transcription factor Runx3 represses the neurotrophin receptor TrkB during lineage commitment of dorsal root ganglion neurons. J Biol Chem. 2007, 282: 24175-24184.View ArticlePubMedGoogle Scholar
- Muhr J, Andersson E, Persson M, Jessell TM, Ericson J: Groucho-mediated transcriptional repression establishes progenitor cell pattern and neuronal fate in the ventral neural tube. Cell. 2001, 104: 861-873.View ArticlePubMedGoogle Scholar
- Kurokawa M: AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis. Int J Hematol. 2006, 84: 136-142.View ArticlePubMedGoogle Scholar
- Durst KL, Hiebert SW: Role of RUNX family members in transcriptional repression and gene silencing. Oncogene. 2004, 23: 4220-4224.View ArticlePubMedGoogle Scholar
- Mitani K: Molecular mechanisms of leukemogenesis by AML1/EVI-1. Oncogene. 2004, 23: 4263-4269.View ArticlePubMedGoogle Scholar
- Aronson BD, Fisher AL, Blechman K, Caudy M, Gergen JP: Groucho-dependent and -independent repression activities of Runt domain proteins. Mol Cell Biol. 1997, 17: 5581-5587.PubMed CentralView ArticlePubMedGoogle Scholar
- Imai Y, Kurokawa M, Tanaka K, Friedman AD, Ogawa S, Mitani K, Yazaki Y, Hirai H: TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation. Biochem Biophys Res Commun. 1998, 252: 582-589.View ArticlePubMedGoogle Scholar
- Yarmus M, Woolf E, Bernstein Y, Fainaru O, Negreanu V, Levanon D, Groner Y: Groucho/transducin-like Enhancer-of-split (TLE)-dependent and -independent transcriptional regulation by Runx3. Proc Natl Acad Sci U S A. 2006, 103: 7384-7389.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu Y, Yang FC, Okuda T, Dong X, Zylka MJ, Chen CL, Anderson DJ, Kuner R, Ma Q: Mechanisms of compartmentalized expression of Mrg class G-protein-coupled sensory receptors. J Neurosci. 2008, 28: 125-132.View ArticlePubMedGoogle Scholar
- Nishimura M, Fukushima-Nakase Y, Fujita Y, Nakao M, Toda S, Kitamura N, Abe T, Okuda T: VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development. Blood. 2004, 103: 562-570.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.